Table 2.

Competing risks models.

	CSH event-free survival	CSH mortality	CSH MACCE	CIF mortality	CIF MACCE
Gender – female	0.88 [0.75, 1.02]	0.91 [0.80, 1.03]	0.95 [0.80, 1.15]	1.11 [0.69, 1.77]	0.87 [0.74, 1.03]
Age	1.04 [1.03, 1.05]***	1.02 [1.01, 1.02]***	1.00 [0.99, 1.01]	1.03 [1.00, 1.05]*	1.03 [1.02, 1.04]***
Hypertension	1.04 [0.88, 1.22]	1.00 [0.88, 1.13]	0.90 [0.75, 1.08]	0.78 [0.47, 1.30]	1.12 [0.95, 1.33]
Smoker	1.12 [0.91, 1.37]	1.01 [0.86, 1.18]	1.00 [0.81, 1.23]	1.53 [0.82, 2.85]	0.99 [0.79, 1.23]
LVEF category number	1.11 [1.02, 1.21]*	1.07 [0.99, 1.15]	0.98 [0.87, 1.10]	0.92 [0.72, 1.19]	1.12 [1.02, 1.23]*
Peripheral arterial disease	1.30 [1.09, 1.56]*	1.16 [0.99, 1.37]	1.04 [0.79, 1.37]	1.30 [0.77, 2.21]	1.25 [1.02, 1.52]*
Previous CHF	1.47 [1.15, 1.88]*	1.41 [1.10, 1.80]*	1.30 [0.80, 2.09]	1.74 [0.91, 3.33]	1.26 [0.93, 1.70]
CKD	1.49 [1.21, 1.83]**	1.27 [1.04, 1.55]*	1.29 [0.93, 1.81]	1.88 [1.09, 3.24]*	1.21 [0.94, 1.55]
Killip	1.30 [1.17, 1.44]***	1.19 [1.08, 1.31]**	1.13 [0.96, 1.33]	1.27 [0.94, 1.72]	1.19 [1.06, 1.35]*
Optimal medical therapy	0.81 [0.70, 0.94]*	0.98 [0.88, 1.10]	1.16 [0.99, 1.36]	0.70 [0.43, 1.14]	0.85 [0.73, 1.00]*

CABG: coronary artery bypass grafting; CHF: congestive heart failure; CIF: cumulative incidence function (Fine–Gray competing risks models); CKD: chronic kidney disease; CSH: cause-specific hazard (Cox competing risks models); LVEF: left ventricle ejection fraction; MACCE: major adverse cardiac and cerebrovascular events.

^*Values in the range 0.001 to <0.05; **values in the range 0.0001–0.001; ***values <0.0001.